The payments have raised concerns that doctors could be influenced to favour specific drugs or prescribe them over talking therapies and lifestyle changes ...

The UK government has doubled the rate that pharmaceutical companies must repay on the sales of newer products to the NHS under the statutory scheme for branded medicines in the second half of 2025, ...

The i Paper found mental healthcare professionals have accepted £1m from pharmaceutical companies since 2021 ...

Hopes that the UK-US trade agreement would give ... protecting thousands of British jobs in key sectors including car manufacturing and steel," said Starmer. "My government has put Britain at ...

UK pharmaceutical companies must pay 23.5%-35.6% of branded medicine sales revenue to the NHS. The UK's share of global pharma R&D investment has dropped from 7.3% to 5.7% in three years ...

"Pharmaceutical industry jobs are especially important here ... to the US are reportedly considering moving their manufacturing from the UK to America, according to RBC analysts.